| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.09 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.09 |